ClinicalMetric / Countries / Portugal
← All Countries
🇵🇹
COUNTRY FEED

Clinical Trials in Portugal

Active recruiting clinical trials with sites in Portugal. Select a condition below to see detailed trial listings.

Total Trials: 28 // Recruiting: 28 // Updated: Daily

Portugal currently has 28 clinical trials with at least one registered site in the country, of which 28 are actively recruiting participants. The most studied conditions at Portugal sites are Lymphoma, C3 Glomerulopathy (C3G), Healthy Adult Participants, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa, eleva GmbH, Repertoire Immune Medicines. By stage, active Portugal trials break down as Phase 1 (4), Phase 2 (3), Phase 3 (3). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Portugal

Lymphoma 2 C3 Glomerulopathy (C3G) 1 Healthy Adult Participants 1 Advanced Malignant Solid Tumor 1 B-Cell Acute Lymphoblastic Leukaemia 1 Hypertension 1 Obstructive Sleep Apnea (OSA) 1 Ischemic Stroke 1 Women's Health: Neoplasm of Breast 1 IBS (Irritable Bowel Syndrome) 1 IBS-D (Diarrhea-predominant) 1 IBS, Mixed Symptoms 1 Reconstructive Surgical Procedures 1 Plastic Surgery 1 Vascular Surgical Procedure 1 Cerebrovascular Disorder 1 Carotid Endarterectomy 1 Mantle Cell Lymphoma (MCL) 1 Temporomandibular Joint Disorders 1 Osteoarthritis Knee Pain 1
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology